So happy our pre-print on daptomycin mechanism of action is now out! Here, we present three main findings: i) daptomycin does not form large membrane pores in either B. subtilis or S. aureus, (1/3)
Thank you to the SAB team & @BBSRC Portfolio Manager for joining our meeting. Lots of new ideas, practical advice and encouraging feedback as we enter the 3rd year of this exciting project.
Super excited that our paper on isoniazid resistance in M. tuberculosis is now published in @NatureComms . Massive effort from all involved, especially lead author Cecilia Wang!!
https://t.co/twXSGL8LQs
Fully-funded @DiMeN_DTP PhD opportunity available in my lab to investigate novel DNA damage repair processes using next generation sequencing and microscopy techniques (co-supervised by @acdarby & @MicKasia). Please RT and contact me if interested.
https://t.co/7a9TYDiHNl
Excited to share my first co-corresponding opinion piece written in collaboration with the wonderful @MojganRabiey https://t.co/eiMqFzF64q. We cover our thoughts on advancements in phage biocontrol for agricultural pathogens and where the field might develop next.
Today is the beginning of the Postdoc Appreciation Week in the UK! Big shout out to our amazing postdocs working on @AVERTproject. You are key drivers in delivering research excellence and we want to thank you for all you do!
#LovePostdocs#NPAW2024#ECRs
Couple of recent publications from our group!!
1) Awesome work from post-doc Will Jowsey showing how drug-resistance in Mtb alters tolerance to cell wall inhibitors!
https://t.co/wT3A0nXff8
(1/2)
We are looking for an Assistant Research Fellow to join the group and work on #phages as part of our @MBIEsci funded work. You must have right to live and work in NZ to be eligible. Details below https://t.co/jLOmcXaOqH please share
Our paper on the mechanism of phage sensing and restriction by toxin-antitoxin-chaperone (TAC) systems is out in @cellhostmicrobe! We study two antiphage TACs: HigBAC and CmdTAC. @gem__atkinson @HenrikStrahl @AHarms485@medfak_LU@lunduniversity
https://t.co/yjThAzxX86
After my PhD, I went through a horrible transition to industry. Today I am at a conference with colleagues I class as friends presenting work I am so so passionate about ❤️
A dual-targeting succinate dehydrogenase and F1Fo-ATP synthase inhibitor rapidly sterilizes replicating and non-replicating Mycobacterium tuberculosis by @CaraAdolph, Chen-Yi Cheung, Gregory M. Cook et al at @otago@microtago@MWC_CoRE https://t.co/UcNV58XUlo